Mech-Mind Robotics has opened its Hong Kong initial public offering, giving public market investors access to a developer of standardized components for embodied intelligence. The company is offering 23,140,590 H shares at an indicative price range of HKD 95.3 to HKD 101.7 each. Trading on the Main Board is expected to begin on September 1 under stock code 09615, following the close of the Hong Kong public offering at noon on August 27.
Offering Details and Pricing
The offering initially consists of 1,157,040 shares in the Hong Kong public offering and 21,983,550 shares in the international offering. The company has granted an overallotment option covering up to 3,471,060 additional shares, representing about 15 percent of the base offering. If the shares are priced at the top of the range and the option is fully exercised, gross proceeds could reach approximately HKD 2.7 billion, or USD 344.4 million, before fees and expenses.
Cornerstone Investors
The IPO has attracted nine cornerstone investors with combined commitments of USD 186 million. Baillie Gifford has committed USD 60 million and Taikang Life Insurance USD 40 million, while Invus, Jane Street, Ghisallo Fund Master, and Ruihua Investment have each committed USD 15 million. NGS Super Fund and E Fund Management have each committed USD 10 million, and Golden Link Worldwide, an indirect wholly owned subsidiary of BYD, has committed USD 6 million.
Standardized Components for Embodied Intelligence
Founded in 2016 by Shao Tianlan, Mech-Mind focuses on intelligent robot components rather than complete robot bodies. Its products span perception, decision-making, and manipulation, including Mech-GPT, Mech-DLK, Mech-Eye industrial 3D cameras, machine vision software, and the Mech-Hand biomimetic five-finger dexterous hand. The modular design allows integration with industrial robotic arms, dual-arm systems, humanoid robots, and other form factors.
Market Position and Financial Growth
According to China Insights Consultancy, Mech-Mind held about 22.1 percent of the global market for AI and 3D vision-guided non-specialty intelligent robot components by revenue in 2025, ranking first. Revenue increased from RMB 180.8 million in 2023 to RMB 268.8 million in 2024 and RMB 388.8 million in 2025, a compound annual growth rate of 46.6 percent. First quarter 2026 revenue rose 73.1 percent year on year to RMB 106.9 million, while gross margin reached 64.8 percent.
Losses and Spending
The company remains loss-making despite its rapid revenue growth. Its loss from operations was RMB 145.2 million in 2025 and RMB 45.5 million in the first quarter of 2026. Research and development expenses were RMB 112.7 million in 2025 and RMB 38.5 million in the first quarter of 2026, while adjusted loss was RMB 109 million in 2025 and RMB 33.5 million in the first quarter of 2026 respectively.
International Expansion
Overseas revenue grew from RMB 58.6 million in 2023 to RMB 97.7 million in 2024 and RMB 195.5 million in 2025, a compound annual growth rate of 82.7 percent. International sales accounted for 50.3 percent of total revenue in 2025 before easing to 44 percent in the first quarter of 2026. The company has subsidiaries in Tokyo, Seoul, Chicago, and Munich, and its products have certifications in the United States, the European Union, Canada, the United Kingdom, Japan, and South Korea.
Use of IPO Proceeds
Mech-Mind plans to allocate about 31.8 percent of net IPO proceeds to research and development for products and technologies. Another 25.2 percent is earmarked for expanding the product portfolio and application scenarios, while 29.4 percent will fund global expansion and commercialization. About 5 percent will support production capacity and operational efficiency, with the remaining 8.6 percent allocated to working capital and general corporate purposes.
Mech-Mind's IPO represents a test of investor appetite for a robotics company selling intelligence components rather than complete robots. The company brings a growing deployment base, improving gross margins, rising repeat business, and expanding international sales to the public market. Execution against its research and commercial goals will determine whether it can translate those strengths into sustained value.